BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18786335)

  • 1. Clinical inquiries: is there a well-tested tool to detect drug-seeking behaviors in chronic pain patients?
    Gianutsos LP; Safranek S; Huber T
    J Fam Pract; 2008 Sep; 57(9):609-10. PubMed ID: 18786335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a screener and opioid assessment measure for patients with chronic pain.
    Butler SF; Budman SH; Fernandez K; Jamison RN
    Pain; 2004 Nov; 112(1-2):65-75. PubMed ID: 15494186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
    Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
    Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management.
    Moore TM; Jones T; Browder JH; Daffron S; Passik SD
    Pain Med; 2009 Nov; 10(8):1426-33. PubMed ID: 20021601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP).
    Akbik H; Butler SF; Budman SH; Fernandez K; Katz NP; Jamison RN
    J Pain Symptom Manage; 2006 Sep; 32(3):287-93. PubMed ID: 16939853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.
    Chou R; Fanciullo GJ; Fine PG; Miaskowski C; Passik SD; Portenoy RK
    J Pain; 2009 Feb; 10(2):131-46. PubMed ID: 19187890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
    Wiedemer NL; Harden PS; Arndt IO; Gallagher RM
    Pain Med; 2007; 8(7):573-84. PubMed ID: 17883742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.
    Michna E; Ross EL; Hynes WL; Nedeljkovic SS; Soumekh S; Janfaza D; Palombi D; Jamison RN
    J Pain Symptom Manage; 2004 Sep; 28(3):250-8. PubMed ID: 15336337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of various risk screening methods in predicting discharge from opioid treatment.
    Jones T; Moore T; Levy JL; Daffron S; Browder JH; Allen L; Passik SD
    Clin J Pain; 2012 Feb; 28(2):93-100. PubMed ID: 21750461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study.
    Jamison RN; Link CL; Marceau LD
    Pain Med; 2009 Sep; 10(6):1084-94. PubMed ID: 19671087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine toxicology testing in chronic pain management.
    Cone EJ; Caplan YH
    Postgrad Med; 2009 Jul; 121(4):91-102. PubMed ID: 19641275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
    Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
    Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of urine toxicology in chronic opioid analgesic therapy.
    Compton P
    Pain Manag Nurs; 2007 Dec; 8(4):166-72. PubMed ID: 18036504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spanish translation and linguistic validation of the screener and opioid assessment for patients with pain-revised (SOAPP-R).
    Butler SF; Zacharoff KL; Budman SH; Jamison RN; Black R; Dawsey R; Ondarza A
    Pain Med; 2013 Jul; 14(7):1032-8. PubMed ID: 23590454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain.
    Wu SM; Compton P; Bolus R; Schieffer B; Pham Q; Baria A; Van Vort W; Davis F; Shekelle P; Naliboff BD
    J Pain Symptom Manage; 2006 Oct; 32(4):342-51. PubMed ID: 17000351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An opioid screening instrument: long-term evaluation of the utility of the Pain Medication Questionnaire.
    Holmes CP; Gatchel RJ; Adams LL; Stowell AW; Hatten A; Noe C; Lou L
    Pain Pract; 2006 Jun; 6(2):74-88. PubMed ID: 17309714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of urine drug testing for patients on opioid therapy.
    Pergolizzi J; Pappagallo M; Stauffer J; Gharibo C; Fortner N; De Jesus MN; Brennan MJ; Richmond C; Hussey D;
    Pain Pract; 2010; 10(6):497-507. PubMed ID: 20412503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients.
    Adams LL; Gatchel RJ; Robinson RC; Polatin P; Gajraj N; Deschner M; Noe C
    J Pain Symptom Manage; 2004 May; 27(5):440-59. PubMed ID: 15120773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.